Emergent BioSolutions Revenue and Competitors
Estimated Revenue & Valuation
- Emergent BioSolutions's estimated annual revenue is currently $1.6B per year.
- Emergent BioSolutions's estimated revenue per employee is $700,637
- Emergent BioSolutions's total funding is $36.5M.
- Emergent BioSolutions's current valuation is $2.8B. (January 2022)
Employee Data
- Emergent BioSolutions has 2355 Employees.
- Emergent BioSolutions grew their employee count by -18% last year.
Emergent BioSolutions's People
| Name | Title | Email/Phone |
|---|---|---|
1 | GM & VP Government Business | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | VP and Head, Science & Development Project Management and Business Operations | Reveal Email/Phone |
4 | VP & General Manager | Reveal Email/Phone |
5 | VP, Sales & Field Operations | Reveal Email/Phone |
6 | VP, Business Operations | Reveal Email/Phone |
7 | VP Financial Planning Analysis | Reveal Email/Phone |
8 | VP, Marketing | Reveal Email/Phone |
9 | VP & General Manager | Reveal Email/Phone |
10 | VP, Enterprise Business Applications | Reveal Email/Phone |
Emergent BioSolutions Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.3M | 2 | -60% | N/A | N/A |
#2 | $2.9M | 38 | -31% | $17.5M | N/A |
#3 | $2.9M | 38 | -33% | $10.5M | N/A |
#4 | $19.8M | 128 | 0% | $69.4M | N/A |
#5 | $9.6M | 62 | -15% | N/A | N/A |
#6 | $1.4M | 9 | 0% | N/A | N/A |
#7 | $2.5M | 16 | 0% | N/A | N/A |
#8 | $7.4M | 48 | 0% | N/A | N/A |
#9 | $0.2M | 1 | -83% | N/A | N/A |
#10 | $1.7M | 11 | 22% | N/A | N/A |
What Is Emergent BioSolutions?
Emergent BioSolutions is a biologics company focused on the research, development and manufacture of novel vaccines and related products for prophylactic and therapeutic use against common diseases and biological weapons of mass destruction. Its subsidiaries are BioPort Corporation, the primary manufacturing operation, headquartered in Lansing, Michigan, and research-focused Antex Biologics, located in Gaithersburg, Maryland.
keywords:N/A
$36.5M
Total Funding
2355
Number of Employees
$1.6B
Revenue (est)
-18%
Employee Growth %
$2.8B
Valuation
N/A
Accelerator
Emergent BioSolutions News
Analysts expect the company to announce earnings of $0.23 per share for the quarter. Emergent BioSolutions has set its Q1 2022 guidance at EPS...
Analysts expect the company to announce earnings of $0.23 per share for the quarter. Emergent BioSolutions has set its Q1 2022 guidance at EPS...
Cim Investment Management Inc.'s holdings in Emergent BioSolutions were worth $443,000 as of its most recent filing with the Securities and...
Cim Investment Management Inc.'s holdings in Emergent BioSolutions were worth $443,000 as of its most recent filing with the Securities and...
Other Companies in Gaithersburg
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1113.6M | 3867 | 5% | N/A |
#2 | $706.1M | 4945 | N/A | N/A |
#3 | $718.4M | 5031 | 6% | N/A |
#4 | $2188M | 6153 | 7% | N/A |
#5 | $29183.1M | 87218 | 6% | N/A |